share_log

Sensata Technologies Analyst Ratings

Benzinga ·  Jul 26, 2023 09:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/26/2023 22.21% Goldman Sachs $60 → $52 Maintains Buy
04/26/2023 22.21% Truist Securities $49 → $52 Maintains Hold
02/15/2023 29.26% Stifel → $55 Downgrades Buy → Hold
02/09/2023 Wolfe Research Downgrades Outperform → Peer Perform
02/02/2023 48.06% Cowen & Co. $55 → $63 Maintains Outperform
02/01/2023 29.26% Citigroup $42 → $55 Maintains Neutral
02/01/2023 26.91% Baird $52 → $54 Maintains Neutral
11/22/2022 26.91% Jefferies $43 → $54 Upgrades Hold → Buy
10/26/2022 -1.29% Citigroup $45 → $42 Maintains Neutral
10/26/2022 15.16% RBC Capital $51 → $49 Maintains Outperform
10/10/2022 12.81% Stifel $52 → $48 Maintains Buy
10/10/2022 10.46% JP Morgan $42 → $47 Maintains Neutral
07/27/2022 1.06% Truist Securities $46 → $43 Maintains Hold
07/27/2022 5.76% Citigroup $50 → $45 Maintains Neutral
07/14/2022 -1.29% JP Morgan $58 → $42 Maintains Neutral
06/28/2022 17.51% Evercore ISI Group $56 → $50 Maintains In-Line
06/22/2022 29.26% Wolfe Research → $55 Upgrades Peer Perform → Outperform
06/10/2022 33.96% Morgan Stanley $62 → $57 Maintains Overweight
06/01/2022 50.41% Goldman Sachs $72 → $64 Maintains Buy
04/27/2022 45.71% Morgan Stanley $64 → $62 Maintains Overweight
04/27/2022 43.36% RBC Capital $65 → $61 Maintains Outperform
04/08/2022 29.26% Truist Securities $62 → $55 Maintains Hold
04/07/2022 48.06% Barclays $70 → $63 Maintains Overweight
02/14/2022 59.81% UBS $62 → $68 Upgrades Neutral → Buy
02/02/2022 66.86% Morgan Stanley $75 → $71 Maintains Overweight
01/14/2022 57.46% Baird → $67 Downgrades Outperform → Neutral
12/15/2021 76.26% Morgan Stanley $73 → $75 Maintains Overweight
10/18/2021 JP Morgan Downgrades Overweight → Neutral
09/21/2021 48.06% UBS → $63 Initiates Coverage On → Neutral
04/28/2021 71.56% Morgan Stanley $72 → $73 Maintains Overweight
04/28/2021 64.51% RBC Capital $66 → $70 Maintains Outperform
04/19/2021 57.46% Evercore ISI Group $60 → $67 Upgrades In-Line → Outperform
03/22/2021 69.21% Morgan Stanley $68 → $72 Maintains Overweight
03/03/2021 69.21% JP Morgan $61 → $72 Upgrades Neutral → Overweight
01/22/2021 52.76% Barclays $55 → $65 Maintains Overweight
01/11/2021 59.81% Morgan Stanley $63 → $68 Maintains Overweight
12/14/2020 48.06% Morgan Stanley $47 → $63 Upgrades Equal-Weight → Overweight
12/07/2020 Jefferies Downgrades Buy → Hold
10/28/2020 10.46% Morgan Stanley $43 → $47 Maintains Equal-Weight
10/20/2020 33.96% Baird → $57 Initiates Coverage On → Outperform
10/06/2020 29.26% Berenberg → $55 Initiates Coverage On → Buy
10/05/2020 1.06% Morgan Stanley $40 → $43 Maintains Equal-Weight
10/05/2020 29.26% Cowen & Co. $40 → $55 Upgrades Market Perform → Outperform
07/24/2020 15.16% Barclays $44 → $49 Maintains Overweight
06/16/2020 -5.99% Morgan Stanley $35 → $40 Maintains Equal-Weight
05/27/2020 -17.74% Morgan Stanley → $35 Upgrades Underweight → Equal-Weight
04/30/2020 17.51% Canaccord Genuity $45 → $50 Maintains Buy
04/30/2020 -10.69% SunTrust Robinson Humphrey $33 → $38 Maintains Hold
04/30/2020 -1.29% Wells Fargo $40 → $42 Maintains Equal-Weight
04/30/2020 -5.99% BMO Capital $44 → $40 Maintains Market Perform
04/30/2020 -8.34% Citigroup $38 → $39 Maintains Neutral
04/13/2020 -10.69% Goldman Sachs $55 → $38 Upgrades Neutral → Buy
04/03/2020 -22.44% SunTrust Robinson Humphrey $38 → $33 Maintains Hold
04/03/2020 5.76% Canaccord Genuity $57 → $45 Maintains Buy
04/02/2020 -1.29% B of A Securities $55 → $42 Reiterates → Buy
03/18/2020 -17.74% Morgan Stanley $44 → $35 Maintains Underweight
12/17/2019 45.71% RBC Capital → $62 Initiates Coverage On → Outperform
11/22/2019 29.26% Wolfe Research → $55 Downgrades Outperform → Peer Perform
10/16/2019 Oppenheimer Downgrades Outperform → Perform
07/31/2019 3.41% Morgan Stanley $45 → $44 Maintains Underweight
06/17/2019 Longbow Research Downgrades Buy → Neutral
06/06/2019 17.51% Evercore ISI Group → $50 Initiates Coverage On → In-Line
04/22/2019 33.96% JP Morgan $60 → $57 Downgrades Overweight → Neutral
12/04/2018 38.66% Jefferies → $59 Initiates Coverage On → Buy
10/31/2018 3.41% Morgan Stanley $47 → $44 Maintains Underweight
10/31/2018 38.66% Barclays $58 → $59 Maintains Overweight
10/31/2018 22.21% Citigroup $56 → $52 Maintains Neutral
10/31/2018 43.36% Canaccord Genuity $70 → $61 Maintains Buy
09/17/2018 10.46% Morgan Stanley $55 → $47 Downgrades Equal-Weight → Underweight
08/03/2018 64.51% Canaccord Genuity → $70 Initiates Coverage On → Buy

What is the target price for Sensata Technologies (ST)?

The latest price target for Sensata Technologies (NYSE: ST) was reported by Goldman Sachs on July 26, 2023. The analyst firm set a price target for $52.00 expecting ST to rise to within 12 months (a possible 22.21% upside). 14 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Sensata Technologies (ST)?

The latest analyst rating for Sensata Technologies (NYSE: ST) was provided by Goldman Sachs, and Sensata Technologies maintained their buy rating.

When is the next analyst rating going to be posted or updated for Sensata Technologies (ST)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensata Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensata Technologies was filed on July 26, 2023 so you should expect the next rating to be made available sometime around July 26, 2024.

Is the Analyst Rating Sensata Technologies (ST) correct?

While ratings are subjective and will change, the latest Sensata Technologies (ST) rating was a maintained with a price target of $60.00 to $52.00. The current price Sensata Technologies (ST) is trading at is $42.55, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment